Olr1664 inhibitors represent a distinct class of chemical compounds that specifically target the Olr1664 protein, a member of the olfactory receptor family. Olfactory receptors, primarily known for their role in the detection of odorants, are G protein-coupled receptors (GPCRs) that transduce external signals into cellular responses. The Olr1664 receptor, part of the broader GPCR family, is typically associated with the perception of specific odor molecules. However, its inhibitors are of significant interest due to their ability to modulate the activity of this receptor. These inhibitors can be structurally diverse, ranging from small organic molecules to more complex entities, each designed to bind to the active site of the Olr1664 receptor and block its normal function. The binding affinity and specificity of these inhibitors can vary depending on their molecular structure, with some exhibiting strong selectivity for Olr1664 due to particular conformational features that fit the receptor's binding pocket.
The design and synthesis of Olr1664 inhibitors often involve sophisticated techniques such as structure-activity relationship (SAR) studies and computational modeling. These methods help in understanding the interaction between the inhibitor and the receptor at a molecular level, allowing for the optimization of binding efficacy. Additionally, these inhibitors are studied for their physicochemical properties, such as solubility, stability, and permeability, which are crucial for their effectiveness in biological systems. Researchers might explore various synthetic pathways to produce these inhibitors, aiming to achieve the highest possible yield and purity. Furthermore, these compounds are subjected to rigorous analytical techniques, such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry, to confirm their structural integrity and to investigate the nuances of their interactions with the Olr1664 receptor. Overall, the study of Olr1664 inhibitors contributes to a deeper understanding of GPCR modulation and receptor-ligand interactions within this specialized class of olfactory receptors.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Beta-adrenergic antagonist, might modulate GPCR activity, potentially affecting Olr1664. | ||||||
Carvedilol | 72956-09-3 | sc-200157 sc-200157A sc-200157B sc-200157C sc-200157D | 100 mg 1 g 10 g 25 g 100 g | $124.00 $240.00 $530.00 $999.00 $1530.00 | 2 | |
Beta-adrenergic antagonist with alpha-1 blocking activity, could influence Olr1664 signaling. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $51.00 $171.00 $530.00 | 2 | |
Alpha-2 adrenergic receptor antagonist, may affect GPCR signaling pathways related to Olr1664. | ||||||
Labetalol | 36894-69-6 | sc-484723 | 50 mg | $180.00 | ||
Combined alpha and beta blocker, could indirectly affect GPCR pathways, including Olr1664. | ||||||
Pindolol | 13523-86-9 | sc-204847 sc-204847A | 100 mg 1 g | $194.00 $760.00 | ||
Beta-adrenergic antagonist, may influence GPCR-mediated signaling pathways related to Olr1664. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic agonist, could indirectly affect Olr1664 through GPCR modulation. | ||||||
Atropine | 51-55-8 | sc-252392 | 5 g | $204.00 | 2 | |
Muscarinic acetylcholine receptor antagonist, may influence GPCR signaling pathways including Olr1664. | ||||||
Salmeterol | 89365-50-4 | sc-224277 sc-224277A | 10 mg 50 mg | $186.00 $562.00 | 1 | |
Beta-2 adrenergic agonist, potentially affecting GPCR pathways related to Olr1664. | ||||||
Alprenolol | 13655-52-2 | sc-507469 | 50 mg | $130.00 | ||
Beta blocker, could indirectly influence GPCR signaling pathways including Olr1664. | ||||||